Issue 3/1997
Content (12 Articles)
Changes of biological features in breast cancer cells determined by primary chemotherapy
Antonio Frassoldati, Francesca Adami, Chiara Banzi, Mario Criscuolo, Lino Piccinini, Vittorio Silingardi
Breast conserving therapy in stage I & II breast cancer in Korea
Hy-De Lee, Dong-Sup Yoon, Ja-Yun Koo, Chang-Ok Suh, Woo-Hee Jung, Ki-Keun Oh
An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer
Michael Crump, Carol A. Sawka, Gerrit DeBoer, Roger B. Buchanan, James N. Ingle, John Forbes, J. William Meakin, Wendy Shelley, Kathleen I. Pritchard
A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1
Carol A. Sawka, Kathleen I. Pritchard, Wendy Shelley, Gerrit DeBoer, Alexander H.G. Paterson, J. William Meakin, Donald J.A. Sutherland
Captopril modulates hormone receptor concentration and inhibits proliferation of human mammary ductal carcinoma cells in culture
William Small Jr., Agostino Molteni, Yoon T. Kim, Joann M. Taylor, Zehan Chen, William F. Ward
Risk factors for breast cancer: A case-control study of screen-detected breast cancer in Miyagi Prefecture, Japan
Yuko Minami, Noriaki Ohuchi, Akira Fukao, Shigeru Hisamichi
Associations of alcohol, height, and reproductive factors with serum hormone concentrations in postmenopausal Japanese women
Chisato Nagata, Michinori Kabuto, Naoyoshi Takatsuka, Hiroyuki Shimizu
Expression of the prolactin gene in normal and neoplastic human breast tissues and human mammary cell lines: Promoter usage and alternative mRNA splicing
Carla M. Shaw-Bruha, Samuel J. Pirrucello, James D. Shull
Five-day infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patients
M. Zambetti, R. Demicheli, D. De Candis, G. Antonelli, A. Giacobone, M. Terenziani, A. Laffranchi, F. Garbagnati, S. Biasi, G. Bonadonna
Cd44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas
Nathalie Guriec, Béatrice Gairard, Luc Marcellin, Astrid Wilk, Hubert Caldéroli, Robert Renaud, Jean Pierre Bergerat, Francis Oberling
Hepatic toxicity caused by adjuvant CMF/CNF in breast cancer patients and reversal by tamoxifen
Pasi P. Hirvikoski, Eero J. Kumpulainen, Risto T. Johansson
Brca2 hereditary breast cancer pathophenotype
Joseph N. Marcus, Patrice Watson, David L. Page, Steven A. Narod, Patricia Tonin, Gilbert M. Lenoir, Olga Serova, Henry T. Lynch